We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Indian Generics Maker Warned for Repeat CGMP Violations
Indian Generics Maker Warned for Repeat CGMP Violations
Indian drugmaker Jubilant Generics drew an FDA warning letter over repeat quality violations and inadequate complaint investigations at a facility in the northern state of Uttarakhand.